Why it matters: A company may describe a new product, business or acquisition as important before it has earned much money.
Evidence needed: Compare what leaders said in earlier dated reports with what later reports show. Read the report history from oldest to newest. Compare each year's results with competitors over the same period, using matching definitions. Ask what evidence separates management's decisions from changes shared across the industry. For a business or deal they highlight, check its sales, profit, assets and spending against the rest of the company. For each important business, ask which specific product, service or step earns lasting profit, why rivals cannot easily copy it, and whether suppliers, customers or partners may capture the gains instead. Compare several years of evidence, such as prices versus rivals, customers staying or leaving, market share, and profit from new spending. A business can still be strong while its advantage is weakening. Separate growth from acquired businesses from growth in the existing business. Compare the same businesses over matching reporting periods, and check the effects of currency changes and businesses sold. If a filing presents pro forma results, read the assumptions: these show results as if a deal had happened earlier, rather than the actual results for that period. If a target was missed or a measure stops being reported, ask why. If leaders use vague terms for debt, losses or missed targets, find the amounts and dates in the filing and ask what changed. None of these alone proves wrongdoing. If executives receive stock options, ask whether their gains reflect better operating results or mainly retained cash and share repurchases. For executive share awards, read the latest proxy statement to see which results unlock the reward and over what period. Ask whether the terms reward lasting business improvement or a share-price rise shared by the wider industry. Check the latest proxy statement and share-class terms to see who has the votes to elect directors, including any shares with extra votes. If a founder, family or other holder can control decisions while owning a smaller share of the business, ask whether other shareholders can meaningfully challenge the board's spending, acquisitions or leadership. A controlled company is not automatically a poor investment; record the rights and weigh them with the business evidence. Compare important claims in shareholder letters or presentations with the same-period 10-K, 10-Q, notes and proxy. Record any material risk or earnings qualification disclosed in a filing but missing or softened in the summary, together with both document dates. Ask whether the difference changes the investment case. An omission alone does not prove wrongdoing. Check the latest proxy statement and filing notes for related-party transactions: deals with executives, directors, major owners or businesses they control. For a material deal, record who benefits, who pays and whether independent reviewers checked the terms. If the company lends money to a buyer of its own assets, check whether the sale brought in usable cash or left another loan at risk. Board approval alone does not show that a deal benefits outside shareholders. A disclosed conflict is a reason to investigate, not proof of wrongdoing.
If you use insider share transactions in your research, read the dated SEC Form 4, the report of changes in an insider's ownership. Check its transaction code and notes. Separate purchases and sales from share awards, option exercises, gifts and shares used to pay taxes. Check any indication of a trading plan set up earlier and its adoption date. Compare the amount traded with what the person still owns, and check whether the shares are held directly or through another person or entity. A purchase does not prove the stock is cheap, and a sale alone does not show that the business is failing.
When a company highlights a social or environmental program, separate what it spent, what it did and what changed. Training hours, for example, do not show how many people gained lasting work. Check the dates, who was measured and what evidence links the change to the program. Then ask a separate investment question: how could this affect the company's sales, costs, cash needs or ability to borrow? A benefit to society is not automatically cash for shareholders. Keep an unsupported link uncertain; do not add a valuation premium just because the program sounds worthwhile.
For a buyback, compare the dated announcement with repurchase tables and notes in later company filings. Separate the amount authorized from actual purchases, matching dates, units and the program involved. Check any expiry, replacement, termination or unused balance and the company's explanation. Repeat this for earlier programs; a new authorization is not evidence that the earlier one was completed. Reconcile purchases with new shares issued before concluding that existing owners hold more of the business. If repurchases mainly replace shares issued as pay, check the cash spent too. An unchanged share count does not mean the share awards cost owners nothing. Check the plan's terms before treating the full authorization as promised spending. An unused authorization alone does not prove wrongdoing, and completing a buyback does not show that the price paid created value.
This is a manual research question. No conclusion about management's claims has been established for any of the ten companies in this historical sample.
Checking management against industry conditions
Comparing growth after an acquisition
Buybacks and share awards
○ Research check open for this historical sample.